← All trials
NCT06185426
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2021
- Primary completion
- Jun 1, 2023
- Completion date
- Feb 1, 2024
- First posted
- Dec 29, 2023
- Last posted
- Dec 29, 2023
- Enrollment
- 35
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Recep Tayyip Erdogan UniversityLead sponsor
- Recep Tayyip Erdogan UniversityReponsible party - principal investigator
- Recep Tayyip Erdogan UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.